These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27449854)

  • 1. Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.
    Levin MC; Lee S; Gardner LA; Shin Y; Douglas JN; Salapa H
    J Neuroimmunol; 2017 Mar; 304():56-62. PubMed ID: 27449854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease.
    Lee SM; Dunnavant FD; Jang H; Zunt J; Levin MC
    Neurosci Lett; 2006 Jun; 401(1-2):188-93. PubMed ID: 16600502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing.
    Kalume F; Lee SM; Morcos Y; Callaway JC; Levin MC
    J Neurosci Res; 2004 Jul; 77(1):82-9. PubMed ID: 15197740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-1 induced molecular mimicry in neurological disease.
    Lee SM; Morcos Y; Jang H; Stuart JM; Levin MC
    Curr Top Microbiol Immunol; 2005; 296():125-36. PubMed ID: 16323422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease.
    Jernigan M; Morcos Y; Lee SM; Dohan FC; Raine C; Levin MC
    Neurology; 2003 Apr; 60(8):1320-7. PubMed ID: 12707436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease.
    Levin MC; Lee S; Gardner LA; Shin Y; Douglas JN; Groover CJ
    Degener Neurol Neuromuscul Dis; 2012; 2():175-187. PubMed ID: 30890887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.
    Douglas JN; Gardner LA; Salapa HE; Lalor SJ; Lee S; Segal BM; Sawchenko PE; Levin MC
    J Neuroinflammation; 2016 Jul; 13(1):178. PubMed ID: 27391474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP).
    Osame M
    J Neurovirol; 2002 Oct; 8(5):359-64. PubMed ID: 12402162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity due to molecular mimicry as a cause of neurological disease.
    Levin MC; Lee SM; Kalume F; Morcos Y; Dohan FC; Hasty KA; Callaway JC; Zunt J; Desiderio D; Stuart JM
    Nat Med; 2002 May; 8(5):509-13. PubMed ID: 11984596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
    Yukitake M; Sueoka E; Sueoka-Aragane N; Sato A; Ohashi H; Yakushiji Y; Saito M; Osame M; Izumo S; Kuroda Y
    J Neurovirol; 2008 Apr; 14(2):130-5. PubMed ID: 18444084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles.
    Bekenstein U; Soreq H
    Mol Cell Neurosci; 2013 Sep; 56():436-46. PubMed ID: 23247072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody transfection into neurons as a tool to study disease pathogenesis.
    Douglas JN; Gardner LA; Lee S; Shin Y; Groover CJ; Levin MC
    J Vis Exp; 2012 Sep; (67):. PubMed ID: 23051967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity and molecular mimicry in tropical spastic paraparesis/human T-lymphotropic virus-associated myelopathy.
    García-Vallejo F; Domínguez MC; Tamayo O
    Braz J Med Biol Res; 2005 Feb; 38(2):241-50. PubMed ID: 15785836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).
    Azodi S; Nair G; Enose-Akahata Y; Charlip E; Vellucci A; Cortese I; Dwyer J; Billioux BJ; Thomas C; Ohayon J; Reich DS; Jacobson S
    Ann Neurol; 2017 Nov; 82(5):719-728. PubMed ID: 29024167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-cell lymphotropic virus type I and neurological diseases.
    Nagai M; Osame M
    J Neurovirol; 2003 Apr; 9(2):228-35. PubMed ID: 12707853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y; Sato T
    Nihon Rinsho; 2013 May; 71(5):870-5. PubMed ID: 23777097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal molecular mimicry in immune-mediated neurologic disease.
    Levin MC; Krichavsky M; Berk J; Foley S; Rosenfeld M; Dalmau J; Chang G; Posner JB; Jacobson S
    Ann Neurol; 1998 Jul; 44(1):87-98. PubMed ID: 9667596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
    Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune syndrome in the tropical spastic paraparesis/myelopathy associated with human T-lymphotropic virus infections].
    Domínguez MC; Torres M; Tamayo O; Criollo W; Quintana M; Sánchez A; García F
    Biomedica; 2008 Dec; 28(4):510-22. PubMed ID: 19462556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.
    Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.